Tender

Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial

  • London School of Hygiene & Tropical Medicine

F02: Contract notice

Notice identifier: 2021/S 000-029090

Procurement identifier (OCID): ocds-h6vhtk-02f911

Published 22 November 2021, 6:10pm



Section one: Contracting authority

one.1) Name and addresses

London School of Hygiene & Tropical Medicine

Keppel Street,

London

WC1E 7HT

Contact

Paul Pester

Email

paul.pester@lshtm.ac.uk

Telephone

+44 02079272471

Country

United Kingdom

NUTS code

UKI31 - Camden and City of London

National registration number

RC000330

Internet address(es)

Main address

http://www.lshtm.ac.uk

Buyer's address

https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/104519

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=40736&B=LSHTM

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=40736&B=LSHTM

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial

Reference number

LSHTM-2021-29

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.

Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).

Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.

two.1.5) Estimated total value

Value excluding VAT: £975,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 33141310 - Syringes
  • 33141320 - Medical needles
  • 33621000 - Medicinal products for the blood and blood-forming organs
  • 33621200 - Antihaemorrhagics
  • 33698000 - Clinical products
  • 39299100 - Glass ampoules
  • 44617100 - Cartons
  • 79920000 - Packaging and related services

two.2.3) Place of performance

NUTS codes
  • UKI31 - Camden and City of London
Main site or place of performance

LSHTM - Keppel Street, London WC1A 7HT

two.2.4) Description of the procurement

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.

A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.

Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).

Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £975,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

25

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions

GMP and MHRA certification

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

5 January 2022

Local time

1:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 5 April 2022

four.2.7) Conditions for opening of tenders

Date

5 January 2022

Local time

1:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.4) Procedures for review

six.4.1) Review body

The Royal Courts of Justice

The Strand

London

WC2A 2LL

Country

United Kingdom

six.4.4) Service from which information about the review procedure may be obtained

London School of Hygiene & Tropical Medicine

Keppel Street

London

WC1E 7HT

Email

procurement@lshtm.ac.uk

Country

United Kingdom